Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer Article Proceedings Paper

Industry Collaboration

cited authors

  • Lilenbaum, Rogerio; Socinski, Mark A.; Altorki, Nasser K.; Hart, Lowell L.; Keresztes, Roger S.; Hariharan, Subramanian; Morrison, Mark E.; Fayyad, Rana; Bonomi, Phillip

authors

Publication Date

  • October 20, 2006

webpage

published in

category

start page

  • 4825

end page

  • 4832

volume

  • 24

issue

  • 30